Cheng Sohanya Roshan (CIK 0001865796)

Latest company ownership

KPTI - Karyopharm Therapeutics Inc.

Role: EVP & Chief Commercial Officer

Shares held

79,506

Last filed at

Oct 16, 2025

Confidence Score

55.1

2025Q4

Confidence Score History

2022Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Sep 12, 2025	Sep 16, 2025	Karyopharm Therapeutics Inc.	EVP & Chief Commercial Officer	Sell	77.5	+620	1.76%	✗	$2.1K
Mar 4, 2025	Mar 6, 2025	Karyopharm Therapeutics Inc.	EVP & Chief Commercial Officer	Sell	46.3	-3,445	-9.12%	✗	$21.7K
Sep 4, 2024	Sep 5, 2024	Karyopharm Therapeutics Inc.	EVP & Chief Commercial Officer	Sell	47.5	-5,356	-1.31%	✗	$3.9K
Feb 29, 2024	Mar 4, 2024	Karyopharm Therapeutics Inc.	EVP & Chief Commercial Officer	Sell	46.3	-26,949	-6.41%	✗	$31.7K
Sep 1, 2023	Sep 5, 2023	Karyopharm Therapeutics Inc.	EVP & Chief Commercial Officer	Sell	47.5	-7,415	-3.51%	✗	$9.9K
Jun 8, 2023	Jun 12, 2023	Karyopharm Therapeutics Inc.	EVP & Chief Commercial Officer	Sell	50.0	-1,839	-0.86%	✗	$4.3K
Feb 28, 2023	Mar 2, 2023	Karyopharm Therapeutics Inc.	EVP & Chief Commercial Officer	Sell	91.3	+88,761	72.80%	✗	$34K
Jun 13, 2022	Jun 14, 2022	Karyopharm Therapeutics Inc.	Chief Commercial Officer	Sell	47.5	-1,551	-1.70%	✗	$8.1K